NGM Biopharmaceuticals Inc buy Citigroup Inc.
Start price
03.05.23
/
50%
€3.48
Target price
03.05.24
€5.43
Performance (%)
-59.48%
End price
04.05.24
-
Summary
This prediction is currently being closed. The BUY prediction by Citigroup_Inc_ for NGM Biopharmaceuticals Inc is performing very badly with a performance of -59.48%. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| NGM Biopharmaceuticals Inc | - | - | - |
| iShares Core DAX® | 1.917% | 1.088% | 17.187% |
| iShares Nasdaq 100 | 0.911% | 1.674% | 7.930% |
| iShares Nikkei 225® | 0.833% | -1.712% | 12.100% |
| iShares S&P 500 | 0.242% | 1.258% | 3.167% |
Comments by Citigroup_Inc_ for this prediction
In the thread NGM Biopharmaceuticals Inc diskutieren
NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $6.00 price target on the stock.
Ratings data for NGM provided by MarketBeat
In the thread Trading NGM Biopharmaceuticals Inc
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten